List of Tables
Table 1. Vaginal and Vulval Inflammatory Disease Treatment Market Trends
Table 2. Vaginal and Vulval Inflammatory Disease Treatment Market Drivers & Opportunity
Table 3. Vaginal and Vulval Inflammatory Disease Treatment Market Challenges
Table 4. Vaginal and Vulval Inflammatory Disease Treatment Market Restraints
Table 5. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Vaginal and Vulval Inflammatory Disease Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Vaginal and Vulval Inflammatory Disease Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Vaginal and Vulval Inflammatory Disease Treatment
Table 10. Global Vaginal and Vulval Inflammatory Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal and Vulval Inflammatory Disease Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Vaginal and Vulval Inflammatory Disease Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Almirall Basic Information List
Table 32. Almirall Description and Business Overview
Table 33. Almirall Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Almirall (2019-2024)
Table 35. Almirall Recent Developments
Table 36. VenusConcept Basic Information List
Table 37. VenusConcept Description and Business Overview
Table 38. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of VenusConcept (2019-2024)
Table 40. VenusConcept Recent Developments
Table 41. ThermiGen LLC Basic Information List
Table 42. ThermiGen LLC Description and Business Overview
Table 43. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of ThermiGen LLC (2019-2024)
Table 45. ThermiGen LLC Recent Developments
Table 46. Lutronic Basic Information List
Table 47. Lutronic Description and Business Overview
Table 48. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Lutronic (2019-2024)
Table 50. Lutronic Recent Developments
Table 51. BTL Group of Companies Basic Information List
Table 52. BTL Group of Companies Description and Business Overview
Table 53. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of BTL Group of Companies (2019-2024)
Table 55. BTL Group of Companies Recent Developments
Table 56. Viveve Basic Information List
Table 57. Viveve Description and Business Overview
Table 58. Viveve Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Viveve (2019-2024)
Table 60. Viveve Recent Developments
Table 61. Fotona Basic Information List
Table 62. Fotona Description and Business Overview
Table 63. Fotona Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Fotona (2019-2024)
Table 65. Fotona Recent Developments
Table 66. Evofem Biosciences, Inc. Basic Information List
Table 67. Evofem Biosciences, Inc. Description and Business Overview
Table 68. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Evofem Biosciences, Inc. (2019-2024)
Table 70. Evofem Biosciences, Inc. Recent Developments
Table 71. Spero Therapeutics Basic Information List
Table 72. Spero Therapeutics Description and Business Overview
Table 73. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Spero Therapeutics (2019-2024)
Table 75. Spero Therapeutics Recent Developments
Table 76. Hologic Basic Information List
Table 77. Hologic Description and Business Overview
Table 78. Hologic Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Hologic (2019-2024)
Table 80. Hologic Recent Developments
Table 81. Kyung Hee University Hospital Basic Information List
Table 82. Kyung Hee University Hospital Description and Business Overview
Table 83. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Vaginal and Vulval Inflammatory Disease Treatment Business of Kyung Hee University Hospital (2019-2024)
Table 85. Kyung Hee University Hospital Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Vaginal and Vulval Inflammatory Disease Treatment Downstream Customers
Table 89. Vaginal and Vulval Inflammatory Disease Treatment Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Vaginal and Vulval Inflammatory Disease Treatment Product Picture
Figure 2. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Vaginal and Vulval Inflammatory Disease Treatment Report Years Considered
Figure 5. Global Vaginal and Vulval Inflammatory Disease Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaginal and Vulval Inflammatory Disease Treatment Revenue in 2023
Figure 7. Vaginal and Vulval Inflammatory Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Vaginal Dryness Picture
Figure 9. Vaginal Burning Picture
Figure 10. Vaginal Discharge Picture
Figure 11. Genital Itching Picture
Figure 12. Recurrent Urinary Tract Infections Picture
Figure 13. Urinary Incontinence Picture
Figure 14. Others Picture
Figure 15. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Hospital Pharmacies
Figure 18. Product Picture of Specialty Clinics
Figure 19. Product Picture of Others
Figure 20. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Vaginal and Vulval Inflammatory Disease Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Vaginal and Vulval Inflammatory Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Vaginal and Vulval Inflammatory Disease Treatment Sales Value (%), (2019-2030)
Figure 33. United States Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. China Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. China Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. India Vaginal and Vulval Inflammatory Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. India Vaginal and Vulval Inflammatory Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Vaginal and Vulval Inflammatory Disease Treatment Industrial Chain
Figure 55. Vaginal and Vulval Inflammatory Disease Treatment Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
